Techh.info/biomedtechnology hourly

Cancer

headlines texts
06.04.2020
14:17 News-Medical.Net Fiber-rich diet linked with reduced risk of breast cancer

Consuming a diet high in fiber was linked with a reduced incidence of breast cancer in an analysis of all relevant prospective studies. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

Скрыть анонс
07:19 NYT Health High-Fiber Foods Linked to Lower Breast Cancer Risk

Foods high in soluble fiber like oatmeal, nuts and beans were associated with reduced breast cancer incidence.

Скрыть анонс
05.04.2020
00:02 ScienceDaily.com COPD linked to heightened risk of lung cancer in people who have never smoked

COPD, short for chronic obstructive pulmonary disease, is linked to a heightened risk of lung cancer in people who have never smoked.

Скрыть анонс
04.04.2020
23:48 ScienceDaily.com Using sponges to wipe out cancer

Manzamine A, a natural product derived from certain groups of sponges, can block the growth of cervical cancer cells, report researchers. Manzamine A targets a protein that is highly expressed in many cancers, including cervical cancer, and is the first reported inhibitor of this protein.

Скрыть анонс
02:33 Medscape.Com Colorectal Cancer: Proposed Guidelines for the COVID-19 Era

Drs David and Rachel Kerr of the University of Oxford present suggested guidance for the management of patients during the novel coronavirus pandemic.

Скрыть анонс
03.04.2020
21:39 CancerNetwork.com AACR Calls for Immediate Action Against COVID-19 from Congress for Patients with Cancer

In a letter to Congress, the AACR called for immediate action to be taken to protect patients with cancer against the COVID-19 pandemic.

Скрыть анонс
20:41 Medscape.Com Cancer Patients Are Concerned About Cancer, Then COVID-19

Dr Mark Kris discusses how patients with cancer are primarily concerned about their cancer and its consequences, followed by concerns about COVID-19.

Скрыть анонс
17:17 CancerNetwork.com Pembrolizumab Induces Significantly Improved PFS in MSI-H/dMMR Colorectal Cancer

The trial evaluating the first-line treatment of pembrolizumab in patients with microsatellite instability-high or mismatch repair deficient unresectable or metastatic colorectal cancer demonstrated improved PFS compared with chemotherapy.

Скрыть анонс
16:27 ScienceDaily.com Starving pancreatic cancer of cysteine may kill tumor cells

In a new study of mice, researchers have found that an experimental drug that breaks down the amino acid cysteine slows pancreatic tumor growth by causing ferroptosis, an unusual form of cell death.

Скрыть анонс
14:11 ScientificAmerican.Com The Challenge of Finding Genome-Based Cancer Treatments

Fighting the disease is like trying to hit a moving target, evolutionarily speaking -- Read more on ScientificAmerican.com

Скрыть анонс
13:38 ClinicalOncology.com No Clear Link Between Higher Opioid Consumption and OIC in Cancer Patients

A retrospective study of cancer patients taking opioid analgesics showed a weak association at most between overall daily opioid consumption and greater severity of self-reported opioid-induced constipation. 

Скрыть анонс
01:54 News-Medical.Net Starving pancreatic cancer cells of cysteine may induce tumor ferroptosis

A new study from Columbia University Irving Medical Center and the Herbert Irving Comprehensive Cancer Center suggests a compound in development for a rare kidney stone disease may have potential against pancreatic cancer.

Скрыть анонс
02.04.2020
23:25 CancerNetwork.com New Blood Test Could Detect More Than 50 Cancer Types

A study found that, utilizing cell-free DNA sequencing leveraging methylation patterns, a new blood test could detect more than 50 cancer types and the location of these cancer types in the body.

Скрыть анонс
21:12 StemCellsPortal.coml Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression

ZURICH (CH), March 2020 — Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage. However, stem cells are also present in cancerous tissues and are involved in cancer progression and metastasis. Nerves are fundamental for regulating the physiological and regenerative processes involving stem cells. However, little is known about the interactions between stem cells and neurons in regenerating tissues and in cancers.A team of researchers led by Thimios Mitsiadis, DDS, Ph.D., professor at the Institute of Oral Biology of the University of Zurich, has now published two studies that elucidate how stem cells promote neuronal growth in tissue regeneration and in cancer progression. The first study compared the interaction of neurons with two different human stem cell populations, namely dental

Скрыть анонс
20:57 StemCellsPortal.coml Stem Cells and Nerves Interact in Tissue Regeneration and Cancer Progression

ZURICH (CH), March 2020 — Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage. However, stem cells are also present in cancerous tissues and are involved in cancer progression and metastasis. Nerves are fundamental for regulating the physiological and regenerative processes involving stem cells. However, little is known about the interactions between stem cells and neurons in regenerating tissues and in cancers.A team of researchers led by Thimios Mitsiadis, DDS, Ph.D., professor at the Institute of Oral Biology of the University of Zurich, has now published two studies that elucidate how stem cells promote neuronal growth in tissue regeneration and in cancer progression. The first study compared the interaction of neurons with two different human stem cell populations, namely dental

Скрыть анонс
19:14 CancerNetwork.com Clinicians Discuss Best Approaches for Treating Patients with Cancer During COVID-19 Pandemic

Clinicians advised the best approaches for treating patients who have been diagnosed or are currently under treatment for cancer during the ongoing COVID-19 pandemic.

Скрыть анонс
17:19 CancerNetwork.com Updated Results for Infigratinib in Metastatic Urothelial Cancer

Researchers reported updated findings of infigratinib in upper tract urothelial carcinoma and urothelial carcinoma of the bladder, supporting the development of phase III studies in this setting.

Скрыть анонс
16:22 Phys.org A 3-D-printed brain could make it easier to find cancer treatments

Glioblastoma is the deadliest form of brain tumor—less than 10 percent of people who are diagnosed with it will survive more than five years.

Скрыть анонс
11:14 Technology.org Turning colon cancer cells around

Using a modified natural substance along with current clinical approaches could improve colon cancer treatment, according to findings

Скрыть анонс
11:14 Technology.org Suspect cells’ ‘neighbor’ implicated in colorectal cancer

Colorectal cancer kills more than 50,000 people a year in the United States alone, but scientists have struggled

Скрыть анонс
02:59 News-Medical.Net Significant global investment in treating children with cancer could save 11 million lives

A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a Lancet Oncology Commission report published by Lancet.

Скрыть анонс
00:52 Yahoo health First he had brain cancer. Then the coronavirus struck his city. One patient’s perilous journey.

When Ronnie Kresel went in for his most recent checkup following chemotherapy on March 21, it wasn’t anything like the ones he’d had before. Upon his arrival at the Southhampton Stony Brook Hospital in Long Island, N.Y., a doctor met Kresel in a hazmat suit in a large tent outside the facility, where he was asked “a series of rapid-fire questions” and then sent to a negative-pressure room, which prevents cross-contamination, for his visit. 

Скрыть анонс
01.04.2020
23:23 NYT Science Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

Although most drugmakers had already pulled the heartburn products months ago, the agency told consumers they should throw out any over-the-counter medications they still had.

Скрыть анонс
23:22 NYT Health Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

Although most drugmakers had already pulled the heartburn products months ago, the agency told consumers they should throw out any over-the-counter medications they still had.

Скрыть анонс
22:44 ExtremeTech.com Researchers Create AI-Powered Blood Test to Detect Cancer

Credit: Pexels The test can detect over 50 different cancers and narrow down tumor location to specific areas of the body. The post Researchers Create AI-Powered Blood Test to Detect Cancer appeared first on ExtremeTech.

Скрыть анонс
19:42 NYT Science Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

Although most drugmakers had already pulled the heartburn products months ago, the agency told consumers they should throw out any over-the-counter medications they still had.

Скрыть анонс
12:36 Technology.org Machine learning can help increase liver cancer screening rates, says Rice U. expert

Targeting patients with machine learning can increase the number of people getting liver cancer screenings, according to a

Скрыть анонс
08:31 News-Medical.Net ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

The European Research Council (ERC) has announced it will support Professor Thomas Blankenstein to the tune of €2.5 million over five years. This year the ERC is awarding Advanced Grants to a total of 158 scientists across Europe.

Скрыть анонс
07:04 News-Medical.Net Researchers identify new therapeutic strategies against cancer

New findings open up to new therapeutic strategies against cancer.IGC Researchers identify signals emitted by the tumor environment, which controls the migrating capacity of cancer cells.

Скрыть анонс
05:10 News-Medical.Net Study examines the effect of Medicaid expansion on head and neck cancer patients

A study published in the JAMA Otolaryngology-Head & Neck Surgery examines the effect of Medicaid expansion on head and neck cancer patients, finding that the expansions under the Affordable Care Act were associated with improved access to care for these patients and selective Medicaid expansion may worsen existing regional disparities in terms of access to care and outcomes.

Скрыть анонс
31.03.2020
23:48 News-Medical.Net New viable therapeutic strategy found for ER+ breast cancer

Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments.

Скрыть анонс
23:38 CancerNetwork.com Guidelines for Treating Patients with Late-Stage Colorectal Cancer

ASCO released new guidelines for treating patients with late-stage colorectal cancer based on previously existing guidelines using an expert panel.

Скрыть анонс
21:14 CancerNetwork.com ACS Guidelines for Cancer Surgeries During COVID-19 Epidemic

The American College of Surgeons released guidelines for triaging surgeries of patients with cancer during the COVID-19 pandemic.

Скрыть анонс
19:28 CancerNetwork.com Findings Support Screening of COVID-19 in Patients with Cancer

Researchers found that patients with cancer demonstrated deteriorating conditions and poor outcomes from the COVID-19 infection.

Скрыть анонс
17:55 News-Medical.Net Potential new method of breast cancer treatment using androgen receptor

Scientists may have discovered a new therapeutic approach to treat ER+ breast cancer using androgen receptor-stimulating drugs.

Скрыть анонс
17:22 News-Medical.Net New blood test detects more than 50 types of cancer, including at early, more treatable stages

Researchers have developed a simple blood test that can detect over 50 types of cancer, often before signs or symptoms.

Скрыть анонс
17:05 Medscape.Com Maintaining Cancer Care in the Face of COVID-19

Four clinicians describe the changes they are making in maintaining cancer care as a result of the COVID-19 pandemic, acknowledging that the 'situation changes every day.'

Скрыть анонс
16:32 FierceBiotech.com Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug

Amgen has become the latest biopharma to try to figure out the hit it may take to its pipeline timings amid the COVID-19 pandemic.

Скрыть анонс
12:41 ClinicalOncology.com Identifying Deficiencies in Inflammatory Breast Cancer Care

A new survey sheds light on real-world deficiencies in treatment of inflammatory breast cancer.

Скрыть анонс
05:14 News-Medical.Net UVA researchers find way to enhance cancer outcomes by examining patients' genetic data

By mining a vast trove of genetic data, researchers at the University of Virginia School of Medicine are enhancing doctors’ ability to treat cancer, predict patient outcomes and determine which treatments will work best for individual patients.

Скрыть анонс
04:39 News-Medical.Net New blood test accurately detects more than 50 types of cancer

Researchers have developed a blood test that could accurately detect up to 50 types of cancers, and some of these detections could be even before the symptoms appear. The test would help physicians detect the origin or the source of cancer within the body explain the researchers from the European Society of Oncology. The study titled, "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA," was published in the latest issue of the journal Annals of Oncology.

Скрыть анонс
04:36 ScienceDaily.com Blood test detects over 50 types of cancer, some before symptoms appear

In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers.

Скрыть анонс
03:01 BBC Health Blood test 'can check for more than 50 types of cancer'

The test could help diagnose tumours sooner, often before any symptoms, scientists hope.

Скрыть анонс
01:29 News-Medical.Net Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), or blood clot, with no excess in major bleeding events, according to Phase 3 trial results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

Скрыть анонс
30.03.2020
23:25 ScienceDaily.com Researchers find way to improve cancer outcomes by examining patients' genes

Genetics researchers say a new approach could benefit all sorts of serious health conditions, and they're urging scientists to quickly pluck 'low hanging fruit' for the benefit of patients.

Скрыть анонс
23:19 CancerNetwork.com Radiation Treatment May Slow Disease Progression for Patients with Prostate Cancer

A recent study analyzed response to treatment of oligometastatic prostate cancer with stereotactic ablative radiotherapy and found improved oncologic outcomes among men.

Скрыть анонс
19:04 CNBC health care Coronavirus: Feds charge Georgia man with billing for fraudulent COVID-19, cancer testing claims

Erik Santos of Georgia is charged with conspiring to defraud federal and private health-care benefit programs "by submitting fraudulent testing claims" for coronavius and genetic cancer screenings.

Скрыть анонс
17:58 News-Medical.Net Weakness in lung and kidney cancer cells could serve as therapeutic target

An important discovery about how some cancers rely on glucose to survive could lead to development of tumor-specific treatments.

Скрыть анонс
17:44 CancerNetwork.com Outcomes of the SARS-CoV-2 Infection in Patients with Cancer Treated in China

Researchers reported on the incidence and outcomes of the SARS-CoV-2 infection, which has been linked to COVID-19, in patients with cancer who were treated at a tertiary cancer institution in Wuhan, China.

Скрыть анонс
17:25 Phys.org Researchers make first direct measurement of the physical force of invading cancer cells

International research led by the University of St Andrews reveals the first direct measurement of the force cancer cells can apply when they invade, giving insights that may lead to possible future cancer treatments.

Скрыть анонс
17:08 Reuters.com Health AstraZeneca's Imfinzi gets FDA nod to target small-cell lung cancer

U.S. regulators have approved AstraZeneca Plc's Imfinzi treatment for use against an aggressive type of lung cancer in previously untreated patients, the group said on Monday, as it moves to expand its specialization in tackling the disease.

Скрыть анонс
10:10 Reuters.com Health AstraZeneca's lung cancer treatment gets FDA nod

The U.S. Food and Drug Administration approved AstraZeneca Plc's combo treatment for a form of lung cancer in previously untreated patients, the drugmaker said on Monday.

Скрыть анонс
29.03.2020
16:27 Technology.org AI taps into human wisdom to deliver a quick and reliable cancer diagnosis

Artificial intelligence is not going to replace doctors any time soon. However, it can become a very useful

Скрыть анонс
28.03.2020
06:04 News-Medical.Net Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Oncotarget Volume 11, Issue 12 reported outside its natural niche, the cultured prostate cancer stem cells lost their tumor-inducing capability and stem cell marker expression after approximately 8 transfers at a 1:3 split ratio.

Скрыть анонс
27.03.2020
23:22 CancerNetwork.com Prostate-Specific Membrane Antigen PET/CT Suitable Imaging for Prostate Cancer

Prostate-specific membrane antigen PET/CT was found to be a suitable replacement for conventional imaging in patients with prostate cancer, providing superior accuracy to the combined findings of CT and bone scanning.

Скрыть анонс
22:37 News-Medical.Net Size of tumor tissue area crucial for reliable cancer prognosis, study shows

The method of choice used for preparing tissue samples can lead to biased results in the analysis of cancer patient survival.

Скрыть анонс
19:38 ScienceDaily.com Microbiome may hold key to identifying HPV-infected women at risk for pre-cancer

Gardnerella bacteria in the cervicovaginal microbiome may serve as a biomarker to identify women infected with human papillomavirus (HPV) who are at risk for progression to precancer, according to a new study.

Скрыть анонс
19:38 ScienceDaily.com Disasters can affect cervical cancer screening for years

Screening is important for the early detection of cervical cancer, but rates were significantly affected, in some areas for years, following a devastating earthquake and tsunami in Japan.

Скрыть анонс
19:31 CancerNetwork.com Outcomes of the SARS-CoV02 Infection in Patients with Cancer Treated in China

Researchers reported on the incidence and outcomes of the SARS-CoV-2 infection, which has been linked to COVID-19, in patients with cancer who were treated at a tertiary cancer institution in Wuhan, China.

Скрыть анонс
17:04 News-Medical.Net New approach shows promise as a treatment for chemo-resistant ovarian cancer

Researchers have made a discovery about the behavior of ovarian cancer cells that could lead to a new treatment approach.

Скрыть анонс
15:40 News-Medical.Net A promising strategy to overcome drug resistance developed by blood cancer cells

In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.

Скрыть анонс
13:51 News-Medical.Net New framework to help guide decisions for prostate cancer radiotherapy during COVID-19 pandemic

In the wake of the COVID-19 pandemic, a team of radiation oncologists from the U.S. and U.K. is recommending a new framework for making decisions about radiation therapy for prostate cancer patients that weighs risks and benefits during these difficult times.

Скрыть анонс
13:36 News-Medical.Net Disasters have a major impact on cervical cancer screening for years

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011, Tohoku University scientists report in the journal PLOS ONE.

Скрыть анонс
12:57 Technology.org When Prostate Cancer Recurs, Adding Hormone Therapy to Radiation May Harm Men with Low PSA Levels

When cancer recurs after prostate surgery, adding long term hormone therapy to radiation therapy may do more harm

Скрыть анонс
04:35 News-Medical.Net Microbiome could help identify pre-cancer risk in women with HPV

A new study published in the open-access journal PLOS Pathogens in March 2020 reports the possible use of the bacteria Gardnerella found in the cervix and vagina of women with Human papillomavirus (HPV) infection, as a marker of precancerous change. The findings could help to find new methods of treatment that involve inducing changes in the microbiome to arrest the course of the disease.

Скрыть анонс
03:15 Medscape.Com How Long Is It Safe to Delay Gynecologic Cancer Surgery?

Many health systems have defined which surgeries they consider permissible during the pandemic, typically by using time parameters (days/weeks/hours) by which a patient would not be caused harm.

Скрыть анонс
01:35 Nanowerk.com Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer

Researchers in the cancer nanomedicine community debate whether use nanoparticles can best deliver drug therapy to tumors passively. Now, new research on human and mouse tumors in mice suggests the question is even more complicated.

Скрыть анонс
26.03.2020
22:14 News-Medical.Net Experimental heart disease drug may treat chemo-resistant ovarian cancer

Most ovarian cancer starts in fallopian tubes. Then it sloughs from its site of origin and floats around in fluid until finding new sites of attachment. It's not easy for cancer cells to survive away from their moorings.

Скрыть анонс
21:47 News-Medical.Net Highly focused radiation may slow disease progression in men with oligometastatic prostate cancer

Highly focused, intense doses of radiation called stereotactic ablative radiation (SABR) may slow progression of disease in a subset of men with hormone-sensitive prostate cancers that have spread to a few separate sites in the body, according to results of a phase II clinical trial of the therapy.

Скрыть анонс
21:32 News-Medical.Net New type of immunotherapy shows promise for future treatment of ovarian cancer

Malignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease is discovered so late that on average only four out of six patients are still alive after five years.

Скрыть анонс
21:22 CancerNetwork.com ESMO Addresses COVID-19 and Cancer Care

The European Society for Medical Oncology released key answers to questions about the coronavirus disease 2019 (COVID-19) as it pertains to cancer care.

Скрыть анонс
18:38 ScienceDaily.com Despite failures, chemo still promising against dangerous childhood brain cancer, DIPG

The pediatric brain cancer known as diffuse intrinsic pontine glioma (DIPG) is almost uniformly fatal. In part, this is due to where and how it grows, forming as a diffuse net of cells in a part of the brainstem called the pons, which controls essential functions like breathing and swallowing. Another factor that makes DIPG especially dangerous is a lack of treatments - currently, there are no targeted therapies or immunotherapies proven effective to treat the condition, and the many chemotherapy clinical trials seeking to treat DIPG have been uniformly unsuccessful.

Скрыть анонс
18:38 ScienceDaily.com Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer

Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can best deliver drug therapy to tumors passively -- allowing the nanoparticles to diffuse into tumors and become held in place, or actively -- adding a targeted anti-cancer molecule to bind to specific cancer cell receptors and, in theory, keep the nanoparticle in the tumor longer. Now, new research on human and mouse tumors in mice suggests the question is even more complicated.

Скрыть анонс
18:02 News-Medical.Net Insights into diagnosis and treatment of rare pediatric brain cancer

Ependymoma is a rare form of brain cancer that implicates children and is often tricky to diagnose. Since effective treatment options can be initiated only after a well-formed diagnosis, there is a dire need among the medical community to identify markers for ependymoma, which in turn, will help oncologists tailor therapy better.

Скрыть анонс
17:50 Phys.org Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer

Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can best deliver drug therapy to tumors passively—allowing the nanoparticles to diffuse into tumors and become held in place, or actively—adding a targeted anti-cancer molecule to bind to specific cancer cell receptors and, in theory, keep the nanoparticle in the tumor longer. Now, new research on human and mouse tumors in mice by investigators at the Johns Hopkins Kimmel Cancer Center suggests the question is even more complicated.

Скрыть анонс
17:38 CancerNetwork.com Polypharmacy in Patients with Cancer Over 65 May Predict Hospitalization

In this study, polypharmacy during the 6-month time period pre-IV chemotherapy was highly predictive of post-chemotherapy inpatient hospitalization.

Скрыть анонс
16:55 FierceBiotech.com Safely overcoming resistance to checkpoint inhibition in cancer by blocking a growth factor

Despite the strong anti-cancer effects of PD-1/L1 inhibitors, many patients still don’t respond to these drugs, which work by lifting the brakes tumors use to evade immune attacks. Scientists at Scholar Rock found that selectively targeting TGF-beta1 growth factor with its investigational drug SRK-181 could overcome resistance to checkpoint inhibitors.

Скрыть анонс
16:25 Medscape.Com 5 Key Targeted Therapy Advances for Lung Cancer

Drs West and Aggarwal share their thoughts on the past decade's targeted therapy innovations, and how they may keep going well into the 2020s.

Скрыть анонс
14:51 FierceBiotech.com Cancer biotech Viracta nabs Nordic Nanovector exec as CMO

Lisa Rojkjaer, M.D., has been named Viracta’s new chief medical officer as Nordic Nanovector adds interim replacement.

Скрыть анонс
12:22 BBC Health Coronavirus: Cancer patient's chemotherapy put on hold

Nancy Carter-Bradley is calling on the health secretary to ring-fence cancer treatment.

Скрыть анонс
03:00 News-Medical.Net Transmission of COVID-19 among cancer patients in China

Researchers from Zhongnan Hospital of Wuhan University in China in collaboration with those from the National Cancer Centre Singapore, have come up with a study that reveals the transmission of the SARS-CoV-2 or novel coronavirus among patients with cancer in China.

Скрыть анонс
01:18 News-Medical.Net Despite failures, chemotherapy still promising against fatal pediatric brain cancer

The pediatric brain cancer known as diffuse intrinsic pontine glioma is almost uniformly fatal. In part, this is due to where and how it grows, forming as a diffuse net of cells in a part of the brainstem called the pons, which controls essential functions like breathing and swallowing.

Скрыть анонс
25.03.2020
23:07 News-Medical.Net Overexpression of hPCL3S could contribute to tumor progression in prostate cancer

The cover for issue 12 of Oncotarget features Figure 11, "Global analyses of the RNA-Seq data of LNCaP empty vector and LNCaP cells overexpressing hPCL3S (Clone 12)" by Abdelfettah, et al.

Скрыть анонс
22:27 Drugs.com COVID-19 May Force Some Cancer Patients to Delay Treatment

WEDNESDAY, March 25, 2020 -- Early findings involving cancer patients from Wuhan, China -- the original epicenter of the COVID-19 pandemic -- suggest that many contracted the coronavirus while undergoing treatment in the hospital. That could mean...

Скрыть анонс
21:51 Nature.Com Cancer drug trials on hold amid coronavirus disruption

Скрыть анонс
21:45 CancerNetwork.com Biomarkers of Carcinogens Linked to Bladder Cancer in Urine of E-Cigarette Users

Biomarkers of carcinogens, including several with a strong link to bladder cancer, were found to be present in the urine of e-cigarette users.

Скрыть анонс
20:16 News-Medical.Net Lung cancer medication may have benefits for patients with metastatic brain cancers

A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's Hospital of Unity Health Toronto and Harvard Medical School.

Скрыть анонс
19:36 Reuters.com Health China suspends Bristol-Myers' cancer drug sales over findings at U.S. plant

Sales of Bristol-Myers Squibb Co's cancer drug Abraxane have been suspended in China based on findings at a third-party manufacturing plant in the United States.

Скрыть анонс
19:31 Nature.Com Dietary modifications for enhanced cancer therapy

Скрыть анонс
19:31 Nature.Com Integrating genomic features for non-invasive early lung cancer detection

Скрыть анонс
19:31 Nature.Com A genomic and epigenomic atlas of prostate cancer in Asian populations

Скрыть анонс
18:55 AzoNano.com Graphene-Based Biosensors Sense DNA Cancer Markers

DNA cancer markers passing through the blood or serum of a patient can potentially be detected through graphene-based biosensors, which could usher in a period of liquid biopsy. Conversely, plenty of...

Скрыть анонс
18:28 News-Medical.Net Cancer could potentially be treated with new immunotherapy approach, say researchers

Researchers have made a discovery about EGR4 that could instigate a new immunotherapy approach to treating cancer.

Скрыть анонс
17:57 News-Medical.Net Researchers investigate how cellular protein shredders can be programmed to fight cancer

An international team of researchers led by the Universities of Bonn and Ulm has investigated how a cell's own "protein shredder" can be specifically programmed to fight cancer.

Скрыть анонс
17:54 Nature.Com How AI is improving cancer diagnostics

Скрыть анонс
17:54 Nature.Com Research round-up: Cancer diagnosis

Скрыть анонс
17:54 Nature.Com Will a test to detect early pancreatic cancer ever be possible?

Скрыть анонс
17:54 Nature.Com Better cancer screening in resource-poor nations

Скрыть анонс
17:54 Nature.Com Cancer diagnosis

Скрыть анонс
17:54 Nature.Com How cancer genomics is transforming diagnosis and treatment

Скрыть анонс